Alaska Airlines launches new era of widebody international flying in Seattle with daily nonstop service to Tokyo Narita operated by Hawaiian Airlines — Neutral
ALK PRNewsWire — May 12, 2025We're transforming Alaska's hometown airport into the West Coast's premier global gateway We're planning for at least 12 international destinations with long-haul aircraft from Seattle by 2030 Nonstop transpacific flights between Seattle and Seoul Incheon begin in September SEATTLE , May 12, 2025 /PRNewswire/ -- Alaska Airlines celebrates a new global connection between the Pacific Northwest and Japan with an inaugural flight today between our hometown hub in Seattle and Tokyo Narita, operated by Hawaiian Airlines' long-haul aircraft. The new service marks the start of daily nonstops between the two dynamic cities and the beginning of a new era of …

FCT Partners with Interac to Transform Identity Verification in Real Estate Transactions — Neutral
FAF Business Wire — May 12, 2025OAKVILLE, Ontario--(BUSINESS WIRE)--FCT, Canada's leading provider of title insurance and real estate technology, today announced an agreement with Interac Corp. (Interac) to integrate the Interac Verified™ credential service into FCT's real estate technology solutions. The agreement and pending integration set the stage for broader adoption of secure and reusable digital identity credentials across the Canadian real estate ecosystem, marking a major step toward a national standard for digitall.

Cerabyte Secures Strategic Investment from Western Digital — Neutral
WDC Business Wire — May 12, 2025SANTA CLARA, Calif., & MUNICH--(BUSINESS WIRE)--Cerabyte, the pioneer of ceramic-based data storage solutions, today announced a strategic investment from Western Digital Corp. (NASDAQ: WDC), a leading developer and manufacturer of storage solutions, including hard disk drives. The partnership will accelerate the development of Cerabyte's ground-breaking ceramic data storage technology, designed to meet the growing demand for permanent accessible long-term data storage in existing and new use c.

Atlanta Braves Holdings Reports First Quarter 2025 Financial Results — Neutral
BATRA Business Wire — May 12, 2025ATLANTA--(BUSINESS WIRE)--Atlanta Braves Holdings, Inc. (“ABH”) (Nasdaq: BATRA, BATRK) today reported first quarter 2025 results. Headlines include: Total revenue grew to $47 million in the first quarter of 2025, up 27% from the prior year period. Baseball revenue increased 30% from the prior year period to $29 million. Mixed-use development revenue grew 23% from the prior year period to $19 million. Mixed-Use Development generated $13 million of Adjusted OIBDA(1) in the first quarter of 2025,.

Q1 revenues increased 412% year over year, driven by AI Nose products Delivers strong turnaround from gross loss to gross profit in Q1 AI Nose gains traction beyond healthcare with strategic partnerships in robotics and semiconductor sectors VELDONA® program advances with TFDA and IRB Approvals for two clinical trials in Taiwan SAN DIEGO, CALIFORNIA / ACCESS Newswire / May 12, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos", or the "Company") today announced its financial results for the first quarter ended March 31, 2025. Chun-Hsien (Eddy) Tsai, Chairman of the Board, President, and Chief Executive Officer of Ainos, commented, "Q1 2025 represents …

IMUNON Reports First Quarter 2025 Financial Results and Provides Business Update — Neutral
IMNN GlobeNewsWire — May 12, 2025First site initiated for Phase 3 OVATION 3 study of IMNN-001 in treatment of newly diagnosed advanced ovarian cancer New data from Phase 2 OVATION 2 study of IMNN-001 accepted for oral presentation at 2025 ASCO Annual Meeting Company to hold conference call today at 11:00 a.m. ET LAWRENCEVILLE, N.J.

Medera to Present Late-Breaking Phase 1/2a Clinical Trial Results at Heart Failure 2025 Congress — Neutral
KVAC GlobeNewsWire — May 12, 2025BOSTON, May 12, 2025 (GLOBE NEWSWIRE) -- Medera Inc. (“Medera”), a clinical-stage biopharmaceutical company focused on targeting cardiovascular diseases by developing a range of next-generation therapeutics, today announced that data from its First-In-Human Phase 1/2a MUSIC-HFpEF clinical trial investigating its adeno-associated virus-based gene therapy candidate SRD-002 in heart failure with preserved ejection fraction (HFpEF) will be presented at the upcoming Heart Failure 2025 Congress taking place May 17-20, 2025, in Belgrade, Serbia.

CASI Pharmaceuticals Enters Into Definitive Agreement for the Divestiture of Assets in China — Neutral
CASI Accesswire — May 12, 2025BEIJING, CHINA / ACCESS Newswire / May 12, 2025 / CASI Pharmaceuticals, Inc. (Nasdaq:CASI), ("CASI" or the "Company"), a Cayman incorporated biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today announced that it has entered into a definitive Equity and Assets Transfer Agreement (the "Equity and Assets Transfer Agreement") with Kaixin Pharmaceuticals Inc. ("Kaixin Pharmaceuticals"), a Cayman Islands incorporated entity wholly-owned by Dr. Wei-Wu He, Chairman of the board of directors and CEO of the Company and two direct wholly-owned subsidiaries of the Company in China (the "Target Companies"), pursuant to which the Company shall sell …

MSTY has done incredibly well with a 12-month trailing dividend yield of 123%, but I don't believe this performance will continue in 2025. Of the three underlying mechanisms MSTY uses to generate income, only one is likely to work in a bear market – and even then, only in a muted fashion. I suspect the bull run in BTC still has some room left, and it may reach around $225,000 before entering a bear phase.

3 ETF Strategies to Follow on Temporary U.S.-China Trade Deal — Positive
SMH XLK XLY Zacks Investment Research — May 12, 2025With the U.S. and China hitting pause on tariffs, markets are breathing a sigh of relief. Here are three ETF that strategies investors can follow to capitalize on the trade truce.

TaskUs Shareholders Interesting In Pursuing Potential Claims Should Contact Shareholder Rights Firm Regarding Proposed Buyout — Neutral
TASK PRNewsWire — May 12, 2025NEW YORK , May 12, 2025 /PRNewswire/ -- Julie & Holleman LLP, a top-tier shareholder rights firm, is investigating the proposed buyout of TaskUs, Inc. (Nasdaq: TASK) by the company's three largest shareholders: private equity firm Blackstone and co-founders Bryce Maddock and Jaspar Weir. For a free consultation, please visit https://julieholleman.com/taskus-inc/.

Koppers Management Participating in B. Riley Securities Investor Conference — Neutral
KOP PRNewsWire — May 12, 2025PITTSBURGH , May 12, 2025 /PRNewswire/ -- Koppers Holdings Inc. (NYSE: KOP), an integrated global provider of treated wood products, wood treatment chemicals and carbon compounds, today announced that the company will host meetings with the investment community as part of its participation in the B. Riley Securities Investor Conference, which will be in person on May 21, 2025, in Marina del Rey, California.

Prediction: Buy Archer Aviation Even After Today's Earnings — Neutral
ACHR 24/7 Wall Street — May 12, 2025Archer Aviation (ACHR) is scheduled to report Q1 earnings before the opening bell today.

Your New iPhone May Get More Expensive. Apple Won't Blame China Tariffs. — Negative
AAPL Barrons — May 12, 2025After retailer Amazon was blasted by the White House for potentially citing the tariffs as part of the price on goods purchased by U.S. consumers, Apple is determined to avoid a similar fate.

Here's Why You Should Avoid Investing in Donaldson Stock Right Now — Negative
DCI Zacks Investment Research — May 12, 2025DCI experiences weakness in its operations due to softness in the off-road and on-road businesses. Rising expenses are added concerns.

Caledonia Mining: An undervalued 'nugget' in the gold space — Positive
AAAU BAR CMCL DBP DGL GLD GLDM IAU OUNZ SGOL UGL Proactive Investors — May 12, 2025For investors searching for undervalued names in the gold space, broker Cavendish believes Caledonia Mining Corporation PLC (AIM:CMCL, NYSE-A:CMCL) stands out as a compelling opportunity. The Zimbabwe-based gold producer is trading well below its estimated fair value, despite strong free cash flow, consistent dividends and a positive outlook on production.

However, zooming out, shares are up an impressive 465% over the past 12 months and remain firmly in an uptrend, trading above all major moving averages.

Is AEM Stock a Screaming Buy After the 50% YTD Price Rally? — Positive
AEM Zacks Investment Research — May 12, 2025AEM is well-placed on a strong pipeline of growth projects, solid financial health, a favorable gold pricing environment and a healthy growth trajectory.
